Both in Pharmaceuticals
Definium Therapeutics vs Travere Therapeutics
Over the past year DFTX returned +117.2% and TVTX returned +74.0%; their daily moves had a correlation of 0.25.
DFTX +117.2% TVTX +74.0%Growth of $1, one year, split-adjusted
| Metric | DFTX | TVTX |
|---|---|---|
| Price | $33.41 | $49.41 |
| Market cap | $4.49B | $4.66B |
| Today | +2.90% | +0.30% |
| 1 month | −7.8% | −14.3% |
| 6 months | +49.2% | +10.3% |
| Year to date | — | +29.3% |
| 1 year | — | +40.5% |
| Revenue growth (YoY) | — | +36.2% |
| Gross margin | — | 98.7% |
| Net margin | — | −23.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.2× |
| Net cash | $1.05B | -$131.7M |
| Dividend yield | — | — |
| Volatility (60d) | 59.9% | 35.6% |
| Short % of float | 7.6% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).